{"success":true,"data":{"pressRelease":{"id":"151865","rtpr_id":"nPretzW6Qa-20260924","ticker":"VEEV","exchange":"NYSE","all_tickers":["VEEV"],"title":"New Veeva Study Builder Agent to Configure Clinical Studies in as Little as One Day","author":"PR Newswire","published_at":"2026-09-24T11:03:00.690Z","article_body":"New Veeva Study Builder Agent to Configure Clinical Studies in as Little as\nOne Day\nPR Newswire\n\nPLEASANTON, Calif., Sept. 24, 2026\n\nStandards-first agent delivers faster and more consistent EDC and DQS builds\n\nPLEASANTON, Calif., Sept. 24, 2026 /PRNewswire/ -- Veeva Systems\n(https://www.veeva.com/) (NYSE: VEEV) today announced Veeva Study Builder\nAgent, a new AI solution that configures Veeva EDC\n(https://www.veeva.com/products/veeva-edc/) and Veeva DQS\n(https://www.veeva.com/products/veeva-dqs/) (Data Quality System) directly\nfrom a study protocol. By reusing an organization's existing standards and\nleveraging the CDISC Unified Study Definitions Model (USDM), the agent ensures\nfaster, more deterministic study builds.\n\n\n\nStudy Builder Agent configures EDC forms, visits, and edit check rules, as\nwell as CQL-based listings in DQS. It also automates testing, including the\ngeneration of test data. Because the agent builds from the organization's\nexisting standards and follows a coordinated process, the results minimize\ndeviation from standards and are audit-ready by design.\n\n\"Veeva Study Builder Agent will make it much faster to build high-quality\nstudies,\" said Drew Garty, chief technology officer, Veeva Clinical Data.\n\"We're committed to innovations that simplify, standardize, and connect\nclinical trials, and Study Builder Agent is a significant step toward\nachieving that vision.\"\n\nPlanned for early adopter availability in December 2026, Veeva Study Builder\nAgent is part of EDC and requires no additional license. It is delivered as a\nClaude Cowork plugin and installed from a Veeva-managed GitHub repository.\nLearn more about Veeva Clinical Data\n(https://www.veeva.com/products/clinical-data-management/) solutions,\nincluding EDC, DQS, and eCOA, at Veeva R&D and Quality Summit\n(https://www.veeva.com/events/rd-summit/) in Boston October 20-21. The event\nis open exclusively to life sciences industry professionals.\n\nAbout Veeva Systems\nVeeva delivers the industry cloud for life sciences with applications, agents,\ndata, and consulting. Committed to innovation, product excellence, and\ncustomer success, Veeva serves more than 1,500 customers, ranging from the\nworld's largest pharmaceutical companies to emerging biotechs. As a Public\nBenefit Corporation (https://www.veeva.com/pbc/), Veeva is committed to\nbalancing the interests of all stakeholders, including customers, employees,\nshareholders, and the industries it serves. For more information, visit\nveeva.com (http://veeva.com/).\n\nVeeva Forward-Looking Statements\nThis release contains forward-looking statements regarding Veeva's products\nand services and the expected results or benefits from use of our products and\nservices. These statements are based on our current expectations. Actual\nresults could differ materially from those provided in this release and we\nhave no obligation to update such statements. There are numerous risks that\nhave the potential to negatively impact our results, including the risks and\nuncertainties disclosed in our filing on Form 10-Q for the fiscal year ended\nJuly 31, 2026, which you can find here\n(https://www.sec.gov/ixviewer-plus/ix.xhtml?doc=/Archives/edgar/data/0001393052/000139305226000036/veev-20260731.htm#i7e129a0ad48d459ea13c21cd7e2de073_124) (a\nsummary of risks which may impact our business can be found on pages 33 and\n34), and in our subsequent SEC filings, which you can access at sec.gov\n(https://www.sec.gov/).\n\nContact:\n\nDeivis Mercado\nVeeva Systems\n925-226-8821\ndeivis.mercado@veeva.com\n\nView original content to download\nmultimedia:https://www.prnewswire.co.uk/news-releases/new-veeva-study-builder-agent-to-configure-clinical-studies-in-as-little-as-one-day-302888436.html\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS1257191/Veeva-Systems-Logo-v2.jpg?id=OA2968545\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPretzW6Qa-20260924","title":"New Veeva Study Builder Agent to Configure Clinical Studies in as Little as One Day","author":"PR Newswire","ticker":"VEEV","created":"2026-09-24T11:03:00.690Z","tickers":["VEEV"],"exchange":"NYSE","article_body":"New Veeva Study Builder Agent to Configure Clinical Studies in as Little as\nOne Day\nPR Newswire\n\nPLEASANTON, Calif., Sept. 24, 2026\n\nStandards-first agent delivers faster and more consistent EDC and DQS builds\n\nPLEASANTON, Calif., Sept. 24, 2026 /PRNewswire/ -- Veeva Systems\n(https://www.veeva.com/) (NYSE: VEEV) today announced Veeva Study Builder\nAgent, a new AI solution that configures Veeva EDC\n(https://www.veeva.com/products/veeva-edc/) and Veeva DQS\n(https://www.veeva.com/products/veeva-dqs/) (Data Quality System) directly\nfrom a study protocol. By reusing an organization's existing standards and\nleveraging the CDISC Unified Study Definitions Model (USDM), the agent ensures\nfaster, more deterministic study builds.\n\n\n\nStudy Builder Agent configures EDC forms, visits, and edit check rules, as\nwell as CQL-based listings in DQS. It also automates testing, including the\ngeneration of test data. Because the agent builds from the organization's\nexisting standards and follows a coordinated process, the results minimize\ndeviation from standards and are audit-ready by design.\n\n\"Veeva Study Builder Agent will make it much faster to build high-quality\nstudies,\" said Drew Garty, chief technology officer, Veeva Clinical Data.\n\"We're committed to innovations that simplify, standardize, and connect\nclinical trials, and Study Builder Agent is a significant step toward\nachieving that vision.\"\n\nPlanned for early adopter availability in December 2026, Veeva Study Builder\nAgent is part of EDC and requires no additional license. It is delivered as a\nClaude Cowork plugin and installed from a Veeva-managed GitHub repository.\nLearn more about Veeva Clinical Data\n(https://www.veeva.com/products/clinical-data-management/) solutions,\nincluding EDC, DQS, and eCOA, at Veeva R&D and Quality Summit\n(https://www.veeva.com/events/rd-summit/) in Boston October 20-21. The event\nis open exclusively to life sciences industry professionals.\n\nAbout Veeva Systems\nVeeva delivers the industry cloud for life sciences with applications, agents,\ndata, and consulting. Committed to innovation, product excellence, and\ncustomer success, Veeva serves more than 1,500 customers, ranging from the\nworld's largest pharmaceutical companies to emerging biotechs. As a Public\nBenefit Corporation (https://www.veeva.com/pbc/), Veeva is committed to\nbalancing the interests of all stakeholders, including customers, employees,\nshareholders, and the industries it serves. For more information, visit\nveeva.com (http://veeva.com/).\n\nVeeva Forward-Looking Statements\nThis release contains forward-looking statements regarding Veeva's products\nand services and the expected results or benefits from use of our products and\nservices. These statements are based on our current expectations. Actual\nresults could differ materially from those provided in this release and we\nhave no obligation to update such statements. There are numerous risks that\nhave the potential to negatively impact our results, including the risks and\nuncertainties disclosed in our filing on Form 10-Q for the fiscal year ended\nJuly 31, 2026, which you can find here\n(https://www.sec.gov/ixviewer-plus/ix.xhtml?doc=/Archives/edgar/data/0001393052/000139305226000036/veev-20260731.htm#i7e129a0ad48d459ea13c21cd7e2de073_124) (a\nsummary of risks which may impact our business can be found on pages 33 and\n34), and in our subsequent SEC filings, which you can access at sec.gov\n(https://www.sec.gov/).\n\nContact:\n\nDeivis Mercado\nVeeva Systems\n925-226-8821\ndeivis.mercado@veeva.com\n\nView original content to download\nmultimedia:https://www.prnewswire.co.uk/news-releases/new-veeva-study-builder-agent-to-configure-clinical-studies-in-as-little-as-one-day-302888436.html\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS1257191/Veeva-Systems-Logo-v2.jpg?id=OA2968545\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-09-24T11:03:00.76733092Z","server_sent_at_ms":1790247780767},"received_at":"2026-09-24T11:03:00.818Z","source_url":null},"analysis":{"id":"140666","press_release_id":"151865","analysis_json":{"industry":{"label":"Health Care Technology","sector":"Health Care"},"redFlags":[],"eventType":"product_launch","narrative":"Veeva Systems announced Veeva Study Builder Agent, an AI tool that configures Veeva EDC and DQS directly from a study protocol, potentially cutting clinical study builds to as little as one day.\n\nThe agent builds from an organization's existing standards using CDISC USDM, automating forms, edit checks, listings, and test data generation with audit-ready output.\n\nIt will be available to early adopters in December 2026, is included with EDC at no additional license cost, and will be showcased at Veeva's R&D and Quality Summit in Boston on October 20-21.","sentiment":"bullish","agentHooks":{"shouldPost":false,"suggestedAngle":"Veeva extends its AI agent strategy into clinical data builds -- incremental product velocity, not a near-term financial event."},"keyFigures":{"customDimensions":{"availability":"early adopter December 2026","customer_count":1500,"build_time_claim":"as little as one day"}},"quotedText":"Veeva Study Builder Agent will make it much faster to build high-quality studies","namedEntities":{"people":[{"name":"Drew Garty","role":"CTO, Veeva Clinical Data"},{"name":"Deivis Mercado","role":"PR contact, Veeva Systems"}],"products":["Veeva Study Builder Agent","Veeva EDC","Veeva DQS","CDISC Unified Study Definitions Model (USDM)","Claude Cowork"],"companies":[{"name":"Veeva Systems","ticker":"VEEV","relationship":"filer"}],"dollarAmounts":[]},"materialImpact":{"score":2,"reasoning":"Routine AI product announcement for a Study Builder Agent embedded in existing EDC/DQS products at no additional license cost. Availability is only early-adopter in December 2026; no revenue or financial impact stated."},"tickerRelevance":{"others":[],"primary":"VEEV"},"globalImportance":25,"audienceRelevance":30,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"large-cap software (life sciences)","eventGravity":"routine product announcement","revenueImpactStated":false}},"event_type":"product_launch","event_type_secondary":null,"sentiment":"bullish","material_impact_score":2,"narrative":"Veeva Systems announced Veeva Study Builder Agent, an AI tool that configures Veeva EDC and DQS directly from a study protocol, potentially cutting clinical study builds to as little as one day.\n\nThe agent builds from an organization's existing standards using CDISC USDM, automating forms, edit checks, listings, and test data generation with audit-ready output.\n\nIt will be available to early adopters in December 2026, is included with EDC at no additional license cost, and will be showcased at Veeva's R&D and Quality Summit in Boston on October 20-21.","key_figures":{"customDimensions":{"availability":"early adopter December 2026","customer_count":1500,"build_time_claim":"as little as one day"}},"named_entities":{"people":[{"name":"Drew Garty","role":"CTO, Veeva Clinical Data"},{"name":"Deivis Mercado","role":"PR contact, Veeva Systems"}],"products":["Veeva Study Builder Agent","Veeva EDC","Veeva DQS","CDISC Unified Study Definitions Model (USDM)","Claude Cowork"],"companies":[{"name":"Veeva Systems","ticker":"VEEV","relationship":"filer"}],"dollarAmounts":[]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-24T11:03:05.758Z","global_importance":25,"audience_relevance":30,"importance_components":{"tickerTier":"large-cap software (life sciences)","eventGravity":"routine product announcement","revenueImpactStated":false}},"durationMs":4930,"modelName":"glm-5.3-flashx"}}